NRC Health Q1 revenue up 4% to $34.8M; TRCV record $152.1M (+13% YoY)

NRC HEALTH

2026-Q1 EPS reported $0.14 revenue$34,803,000

GAAP net income $3.2M ($0.14 diluted EPS); adjusted net income $4.6M ($0.21 adjusted diluted EPS).
Adjusted EBITDA $9.4M (27% of revenue); cash flow from operations $7.2M up 8% YoY.
Total Recurring Contract Value (TRCV) $152.1M, up 13% YoY, sixth consecutive quarterly increase.
Company signed the largest deal in its 45-year history; new sales and retention reached multi-year highs.
Free cash flow $5.4M (15% of revenue); revenue $34.8M, first YoY growth since 2023.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

NRC HEALTH reported first quarter ended March 31, 2026 results: revenue $34.8 million, net income $3.2 million, EPS $0.14.

Period: first quarter ended March 31, 2026
Revenue: $34.8 million
Net income: $3.2 million
EPS: $0.14
Result: reported results

Exact text from the filing

outcomes driver, helping healthcare organizations turn Human Understanding into measurable, repeatable improvement." First Quarter 2026 Highlights ● Revenue: Total revenue was $34.8 million for the three months ended March 31, 2026, up 4% from the prior year ● Net Income : GAAP net income was $3.2 million, representing 9% of revenue, and Adjusted Net Income* was

View on SEC.gov

1436 earnings releases filed in the last 30 days. Browse all earnings releases →

NRC HEALTH filing history →

Source: SEC EDGAR

accession 0001437749-26-013641

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.